Review
Single-photon emission tomography and dopamine transporter imaging in Parkinson's disease
Affiliations
- PMID: 12442677
Item in Clipboard
Review
Single-photon emission tomography and dopamine transporter imaging in Parkinson's disease
Adv Neurol.
2003.
No abstract available
Similar articles
-
Dopamine receptors in Parkinson's disease: imaging studies.Adv Neurol. 2003;91:65-71. Adv Neurol. 2003. PMID: 12442664 Review. No abstract available.
-
Objective measures for the progression of Parkinson's disease.J Neurol Neurosurg Psychiatry. 2003 Mar;74(3):287. doi: 10.1136/jnnp.74.3.287. J Neurol Neurosurg Psychiatry. 2003. PMID: 12588908 Free PMC article. No abstract available.
-
Can SPET imaging of dopamine uptake sites replace PET imaging in Parkinson's disease? For.Eur J Nucl Med Mol Imaging. 2002 May;29(5):711-4. doi: 10.1007/s00259-002-0814-5. Epub 2002 Mar 23. Eur J Nucl Med Mol Imaging. 2002. PMID: 11976813 No abstract available.
-
Periodic leg movements in patients with Parkinson's disease are associated with reduced striatal dopamine transporter binding.J Neurol. 2003 Jan;250(1):83-6. doi: 10.1007/s00415-003-0957-8. J Neurol. 2003. PMID: 12527997
-
Single-photon emission tomography imaging of dopamine terminal innervation: a potential clinical tool in Parkinson's disease.Eur J Nucl Med. 1994 Jan;21(1):1-5. doi: 10.1007/BF00182298. Eur J Nucl Med. 1994. PMID: 8088279 Review. No abstract available.
Cited by
-
Imaging Dopaminergic Neurotransmission in Neurodegenerative Disorders.J Nucl Med. 2022 Jun;63(Suppl 1):27S-32S. doi: 10.2967/jnumed.121.263197. J Nucl Med. 2022. PMID: 35649651 Free PMC article.
-
Surrogate outcomes in neurology, psychiatry, and psychopharmacology.Dialogues Clin Neurosci. 2006;8(3):345-52. doi: 10.31887/DCNS.2006.8.3/lstaner. Dialogues Clin Neurosci. 2006. PMID: 17117616 Free PMC article. Review.
-
Surrogate endpoints in Parkinson's disease research.Curr Neurol Neurosci Rep. 2003 Jul;3(4):314-20. doi: 10.1007/s11910-003-0008-y. Curr Neurol Neurosci Rep. 2003. PMID: 12930701 Review.
-
In vitro imaging techniques in neurodegenerative diseases.Mol Imaging Biol. 2007 Jul-Aug;9(4):161-75. doi: 10.1007/s11307-007-0088-1. Mol Imaging Biol. 2007. PMID: 17318669 Review.
-
The Qualification of an Enrichment Biomarker for Clinical Trials Targeting Early Stages of Parkinson's Disease.J Parkinsons Dis. 2019;9(3):553-563. doi: 10.3233/JPD-191648. J Parkinsons Dis. 2019. PMID: 31306141 Free PMC article.